Detection of tumour heterogeneity in patients with advanced, metastatic castration-resistant prostate cancer on [ 68 Ga]Ga-/[ 18 F]F-PSMA-11/-1007, [ 68 Ga]Ga-FAPI-46 and 2-[ 18 F]FDG PET/CT: a pilot study.
Kim Magaly PabstRiccardo MeiKatharina LückerathBoris A HadaschikClaudia KeschJosefine RawitzerLukas KesslerLuisa S BodensieckRainer HamacherKelsey L PomykalaStefano FantiKen HerrmannWolfgang P FendlerPublished in: European journal of nuclear medicine and molecular imaging (2024)
Lu]Lu-PSMA-617 RLT based on clinical-decision making had a longer overall survival and could be assigned to the PSMA-dominant phenotype.